Peri-operative chemotherapy with intraperitoneal and intravenous Paclitaxel plus TS-1 for serosa positive gastric cancer patients
- Conditions
- serosa positive gastric cancer
- Registration Number
- JPRN-UMIN000013109
- Lead Sponsor
- Intraperitoneal chemotherapy study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
(i)The occurrence of simultaneous or metachronous (within 5 years) double cancers, with the exception of intramucosal tumor that is curable with local therapy (ii)A history of severe drug hypersensitivity (iii)The presence of active bacterial or fungal infection, and a body temperature over 38 temperature. (iv)Pregnancy or lactation in women of childbearing potential (v)Men who wish the partners pregnancy (vi)The presence of unstable angina, heart failure or a history of myocardial infarction within 6 months (vii)Patients requiring systemic steroid medication (viii)Patients requiring the administration of phenytoin or warfarin potassium (ix)The presence to peptic ulcer or bleeding (x)The presence of severe diarrhea (xi)The presence of antigen-positive serum HBs and/or antibody positive serum HVC (xii)The presence of uncontrollable intestinal paralysis, interstitial pneumonitis or ischemic heart disease (xiii)Patients determined to be inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method percent completion of protocol treatment
- Secondary Outcome Measures
Name Time Method